BMP Pharma Trading AG (BST:BMP)
Germany · Delayed Price · Currency is EUR 8.50
-0.50 (-5.56%)
At close: Aug 28, 2026
BMP Pharma Trading AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.05 | - | 0.04 | 0.04 | 0.01 |
Cash & Short-Term Investments | 0.05 | - | 0.04 | 0.04 | 0.01 |
Cash Growth | - | - | 11.87% | 315.07% | -67.18% |
Accounts Receivable | - | - | 0 | 0 | - |
Other Receivables | 8.04 | 8.22 | 6.93 | 6.89 | 4.68 |
Receivables | 8.04 | 8.22 | 6.93 | 6.89 | 4.68 |
Prepaid Expenses | 0 | 0.01 | 0.01 | 0.01 | 0.01 |
Other Current Assets | 0 | 0.22 | 0.17 | 0.38 | 0.15 |
Total Current Assets | 8.09 | 8.45 | 7.14 | 7.31 | 4.85 |
Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 4.58 | 4.98 | 4.98 | 4.97 | 4.97 |
Total Assets | 12.67 | 13.43 | 12.12 | 12.29 | 9.82 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.03 | 0.02 | 0.02 | 0.02 | 0.04 |
Accrued Expenses | 0.39 | 0.02 | 0.02 | 0.14 | 0.02 |
Current Income Taxes Payable | 2.27 | 2.83 | 1.71 | 0.56 | 0.15 |
Other Current Liabilities | -0 | - | 0 | - | - |
Total Current Liabilities | 2.68 | 2.86 | 1.75 | 0.72 | 0.2 |
Long-Term Debt | - | 0.13 | 0.03 | 0.38 | 0.48 |
Long-Term Deferred Tax Liabilities | 0.37 | 0.39 | 0.39 | 0.39 | 0.39 |
Other Long-Term Liabilities | 0.72 | 1.12 | 1.28 | 0.62 | 0.14 |
Total Liabilities | 3.77 | 4.49 | 3.44 | 2.11 | 1.21 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 5.25 | 5.25 | 5.25 | 5.25 | 5.25 |
Retained Earnings | 3.19 | 3.23 | 2.98 | 4.48 | 2.91 |
Comprehensive Income & Other | 0.45 | 0.45 | 0.45 | 0.45 | 0.45 |
Shareholders' Equity | 8.9 | 8.94 | 8.68 | 10.18 | 8.61 |
Total Liabilities & Equity | 12.67 | 13.43 | 12.12 | 12.29 | 9.82 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | 0.13 | 0.03 | 0.38 | 0.48 |
Net Cash (Debt) | 0.05 | -0.13 | 0.02 | -0.34 | -0.47 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | 0.01 | -0.02 | 0.00 | -0.06 | -0.09 |
Filing Date Shares Outstanding | 5.25 | 5.25 | 5.25 | 5.25 | 5.25 |
Total Common Shares Outstanding | 5.25 | 5.25 | 5.25 | 5.25 | 5.25 |
Working Capital | 5.41 | 5.59 | 5.39 | 6.59 | 4.65 |
Book Value Per Share | 1.69 | 1.70 | 1.65 | 1.94 | 1.64 |
Tangible Book Value | 8.9 | 8.94 | 8.68 | 10.18 | 8.61 |
Tangible Book Value Per Share | 1.69 | 1.70 | 1.65 | 1.94 | 1.64 |